A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Fisker, Ane BNebie, Eric
Schoeps, Anja
Martins, Cesario
Rodrigues, Amabelia
Zakane, Alphonse
Kagone, Moubassira
Byberg, Stine
Thysen, Sanne M
Tiendrebeogo, Justin
Coulibaly, Boubacar
Sankoh, Osman
Becher, Heiko
Whittle, Hilton C
van der Klis, Fiona R M
Benn, Christine S
Sie, Ali
Müller, Olaf
Aaby, Peter
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.Published in
Clin Infect Dis 2018; 66(10):1573-80Publiekssamenvatting
Besides protecting against measles, measles vaccine (MV) may have beneficial non-specific effects. We tested the effect of an additional early MV on mortality and measles antibody levels.PMID
29177407ae974a485f413a2113503eed53cd6c53
10.1093/cid/cix1033
Scopus Count
Collections
Related articles
- Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
- Authors: Garly ML, Balé C, Martins CL, Monteiro M, George E, Kidd M, Dias F, Aaby P, Whittle HC
- Issue date: 2001 Feb 28
- Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
- Authors: Martins C, Garly ML, Bale C, Rodrigues A, Benn CS, Whittle H, Aaby P
- Issue date: 2013 Nov 19
- Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
- Authors: Fisker AB, Ravn H, Rodrigues A, Østergaard MD, Bale C, Benn CS, Aaby P
- Issue date: 2014 Jan 23
- Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
- Authors: Do VA, Biering-Sørensen S, Fisker AB, Balé C, Rasmussen SM, Christensen LD, Jensen KJ, Martins C, Aaby P, Benn CS
- Issue date: 2017 Apr 15
- Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.
- Authors: Martins C, Garly ML, Bale C, Rodrigues A, Njie-Jobe J, Benn CS, Whittle H, Aaby P
- Issue date: 2014 Sep 1